Evidence map›Paper›PMID 34803924›Full record

ArticleFrontiers in endocrinology2021

Oral Antidiabetics and Sleep Among Type 2 Diabetes Patients: Data From the UK Biobank.

Pei Xue, Jiafei Wu, Xiangdong Tang, Xiao Tan, Christian Benedict

Full text read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pei XueDepartment of Neuroscience (Sleep Science, Biomedicinskt centrum (BMC)), Uppsala University, Uppsala, Sweden.
Jiafei WuDepartment of Neuroscience (Sleep Science, Biomedicinskt centrum (BMC)), Uppsala University, Uppsala, Sweden.
Xiangdong TangSleep Medicine Center, Department of Respiratory and Critical Care Medicine, Mental Health Center, Translational Neuroscience Center, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Xiao TanDepartment of Neuroscience (Sleep Science, Biomedicinskt centrum (BMC)), Uppsala University, Uppsala, Sweden.
Christian BenedictDepartment of Neuroscience (Sleep Science, Biomedicinskt centrum (BMC)), Uppsala University, Uppsala, Sweden.

Funding

Medical Research Council MC_PC_17228Medical Research Council MC_QA137853
6 · The paper itself

Abstract

Previous small-scale studies have found that oral antidiabetic therapy is associated with sleep difficulties among patients with type 2 diabetes (T2D). Here, we used data from 11 806 T2D patients from the UK Biobank baseline investigation to examine the association of oral antidiabetic therapy with self-reported difficulty falling and staying asleep and daily sleep duration. As shown by logistic regression adjusted for, e.g., age, T2D duration, and HbA

Indexed as

Biological Specimen BanksData AnalysisAdministration, OralAgedBlood GlucoseCohort StudiesCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMaleMetforminMiddle AgedSleepUnited KingdomBlood GlucoseHypoglycemic AgentsMetformininsomniametforminsleep durationsulphonylureatype 2 diabetesUK Biobank

Identifiers

PMID34803924
PMCPMC8595278

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.